IDA blend - Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in IDA blend was 71.94 as of 2019. Its highest value over the past 19 years was 79.49 in 2016, while its lowest value was 0.00 in 2000.
Definition: Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).
Source: UNAIDS estimates.
See also:
| Year | Value |
|---|---|
| 2000 | 0.00 |
| 2001 | 0.00 |
| 2002 | 1.03 |
| 2003 | 3.39 |
| 2004 | 4.65 |
| 2005 | 11.47 |
| 2006 | 23.15 |
| 2007 | 34.01 |
| 2008 | 46.46 |
| 2009 | 49.81 |
| 2010 | 38.19 |
| 2011 | 52.05 |
| 2012 | 59.30 |
| 2013 | 66.43 |
| 2014 | 74.33 |
| 2015 | 77.96 |
| 2016 | 79.49 |
| 2017 | 76.19 |
| 2018 | 74.59 |
| 2019 | 71.94 |
Aggregation method: Weighted average
Periodicity: Annual
Classification
Topic: Health Indicators
Sub-Topic: Risk factors
